Trial Profile
Neutralizing Antibody Titers 6 Years After the Third Dose of Inactivated Japanese Encephalitis Vaccine and Projected Duration of Protection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Mar 2016
Price :
$35
*
At a glance
- Drugs IC 51 (Primary)
- Indications Japanese encephalitis
- Focus Pharmacodynamics
- 19 Feb 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 18 Feb 2014 New trial record